Suchergebnisse - "Nguyen, Bach"

PubPharm (25)

1

Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1 : 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

enthalten in: Lancet (London, England) | 2014

von Raffi, F. | Babiker, A. | Richert, L. | +117

CommentIn: Lancet. 2014 Nov 29;384(9958):1908-10. - PMID 25103175

2

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies : final results of two randomised, placebo-controlled trials

enthalten in: The Lancet. Infectious diseases | 2013

von Eron, J. | Cooper, D. | Steigbigel, R. | +116

CommentIn: Lancet Infect Dis. 2013 Jul;13(7):561-2. - PMID 23664332

3

Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients : 48-week results from the REALMRK Study

enthalten in: AIDS research and human retroviruses | 2013

von Squires, K. | Bekker, L. | Eron, J. | +56

4

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients : final 5-year results from STARTMRK

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2013

von Rockstroh, J. | DeJesus, E. | Lennox, J. | +80

5

Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection : final results of a randomized, controlled, phase II study (Protocol 004)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2012

von Gotuzzo, E. | Markowitz, M. | Ratanasuwan, W. | +36

6

Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients : week-192 overall and subgroup analyses from STARTMRK

enthalten in: HIV clinical trials | 2012

von DeJesus, E. | Rockstroh, J. | Lennox, J. | +80

ErratumIn: HIV Clin Trials. 2012 Sep-Oct;13(5):preceding 233

7

A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients : SPARTAN study results

enthalten in: HIV clinical trials | 2012

von Kozal, M. | Lupo, S. | DeJesus, E. | +17

8

Raltegravir once daily or twice daily in previously untreated patients with HIV-1 : a randomised, active-controlled, phase 3 non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2011

von Eron, J. | Rockstroh, J. | Reynes, J. | +122

ErratumIn: Lancet Infect Dis. 2011 Dec;11(12):895 Dosage error in article text

9

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients : 156-week results from STARTMRK

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2011

von Rockstroh, J. | Lennox, J. | Dejesus, E. | +13

10

Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies

enthalten in: AIDS (London, England) | 2011

von Rockstroh, J. | Teppler, H. | Zhao, J. | +6